Navigation Links
GNS Healthcare, Inc. Expands Senior Management Team to Leverage the Rapidly Growing Opportunities for 'Big Data' in Healthcare Management
Date:10/14/2011

CAMBRIDGE, Mass., Oct. 14, 2011 /PRNewswire/ -- GNS Healthcare, Inc., a leading provider of 'Big Data' analytical solutions to biopharma, payer, provider and government markets in the U.S. and abroad, announced today a major expansion of its senior management team, positioning the company for substantial growth in the deployment of its technology-enabled service and product offerings across the healthcare industry.  Carol McCall has been named Chief Strategy Officer and David Burke has been named Chief Operating Officer and Chief Financial Officer, effective immediately.  

"Breakthroughs in data generation, capture, management and analytics are changing the landscape of the healthcare industry," commented Colin Hill, CEO of GNS Healthcare.  "These individuals bring complementary expertise to GNS Healthcare that will help us scale our organization to provide for the needs of our growing list of customers."

"Carol is perhaps the leading voice in America today regarding how big data analytics can transform healthcare, and she has first-hand experience within many different organizations – payers, providers, pharmacy benefit managers, consultancies and health information policy bodies," continued Mr. Hill.  Ms. McCall served as VP of R&D at health insurance giant Humana, EVP of Managed Care Business Development at electronic health record pioneer AllScripts Healthcare Solutions and Chief Innovation Officer at Tenzing Health, a subsidiary of Vanguard Health Systems.  

Ms. McCall started her career as a health actuary and has developed a unique background in healthcare innovation, predictive analytics and health services design. Ms. McCall led the R&D efforts in Humana's Innovation Center where she pioneered the use of sophisticated analytic techniques to build a portfolio of prediction, knowledge discovery and simulation models. She launched Humana's
'/>"/>

SOURCE GNS Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KPS Capital Partners to Sell Attends Healthcare, Inc. to Domtar Corporation for $315 Million
2. Top 5 Ways to Get Insider Track on Healthcare, Pharma & Biotech Discoveries & Latest News
3. Medco, State of New Mexico and Community Pharmacists Launch SOCRxATES® Program to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs
4. SinoFresh Healthcare, Inc. Takes Groundbreaking Products to Europe
5. LifeWatch Teams With UnitedHealthcare, The Largest Healthcare Insurer In The United States, As A Preferred National Provider Of Cardiac Monitoring Services To Reduce Patient Costs
6. Troy Healthcare, LLC Acquires Stopain® Brand; Unveils New Pain Relieving Gel Set to Hit Stores in Early 2011
7. LodgeNet Healthcare, MDM Healthcare and Child Health Corporation of America Reach Agreement
8. Graymark Healthcare, Inc. to Host Conference Call to Discuss Q2 Financial Results
9. Americans Losing Confidence in Their Ability to Access and Pay for Healthcare, According to Thomson Reuters Index
10. Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty
11. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  Sage ... new generation of equipment for the testing of ... release of the new Luminary™ Profiler, the industry,s ... light-based measurement in a cost-effective, portable unit. ... the specific needs of the cannabis industry, the ...
(Date:12/19/2014)... -- RESMED INC. (NYSE: RMD ) today announced that ... results on Thursday, January 22, 2015, after the New York ... will be issued after 1:00 p.m. US Pacific Time and ... and future outlook. The earnings call is scheduled ... live webcast of the call can be accessed on ResMed,s ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2ResMed To Announce Second Quarter 2015 Results 2
... 21, 2011 Within the last two years the Lap ... weight loss procedure for obese individuals. As a result, the ... increased as well, with the caliber of skill sometimes varying ... Angeles, a bariatric surgeon named Dr. Michael Feiz has taken ...
... Systems Inc. , a leading cardiac biomarker distributor in China, ... an official letter it received from the China State Food ... the SFDA confirmed that it has investigated Inverness Medical Beijing ... ), and suspects IMB of submitting of a forged copy ...
Cached Medicine Technology:VIP Care for Lap Band Patients Leads to Life Changing Results 2Chinmax Disclaims Liability Following China SFDA's Confirmation that Inverness Medical Beijing is Suspected of Forging SFDA Verification Seal and Approval Date in Submission of Triage BNP Test Registration 2
(Date:12/22/2014)... Florida (PRWEB) December 22, 2014 Give ... holiday season, the gift of health and vitality. , ... offering its three top-selling anti-aging formulas in special Holiday ... free rush delivery. , Each bottle contains cutting-edge, ... areas that don't work as well as we age. ...
(Date:12/22/2014)... 7,178 small business owners and marketing professionals ... and opted instead to join Digital Marketer, an Austin, ... 5th annual “Black Friday Boot Camp”. , ... the 5 hour online training event and raised $50,000 ... two Central Texas based charities dedicated to fighting childhood ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 NAPW ... 2014 Professional Woman of the Year. She is recognized ... the largest, most recognized networking organization of professional women ... the National Association of Professional Women is a vibrant ... Local Chapters. , Ms. Kreider is passionate and committed ...
(Date:12/21/2014)... In this report, the global powered ... product, and application. The market, by power source, ... By product, the market covers the handpieces; power ... market is further subdivided into drills, saws, reamers, ... shavers, wire/pin drivers, and others. Moreover, the power ...
(Date:12/21/2014)... 2014 When families in Coral Gables get ... call? The new answer is Lice Troopers . Located ... their newest treatment center will be the new go-to resource ... without the use of harmful chemicals or pesticides. ... 1, 2015. Like the company’s first clinic (located at 1005 ...
Breaking Medicine News(10 mins):Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2
... Institute researcher Jeff Tyner, Ph.D., has created a way to ... myeloid leukemia using an assay that yields results in just ... Society of Hematology annual meeting in Atlanta, on Monday, Dec. ... assay, called RAPID, because it rapidly delivers the information, has ...
... DIEGO, Dec. 10 ADVENTRX Pharmaceuticals,Inc. (Amex: ... on commercializing proprietary product candidates for the treatment,of ... M. Culley,ADVENTRX,s chief business officer, is scheduled to ... as part of a panel on Better Drugs ...
... Human Resources Professional Brings Diverse Expertise, MIAMI, ... biotherapeutic products to healthcare providers, is pleased,to announce ... Vice President of,Human Resources. Ms. Lopez was most ... & Johnson Company. Her 17-year career began,in Human ...
... States may be less likely to report a family history ... prevention strategies according to a new study. Dr. Heather Orom ... colleagues argue that as a result of being less likely ... as strong a predictor of cancer risk in immigrant populations. ...
... and post-stem cell transplantation results compared to thalidomide and ... ... Pharmaceuticals,Inc. (Nasdaq: MLNM ) reported the presentation of results from ... randomized,Phase III clinical trial. This study compared VELCADE, thalidomide and,dexamethasone (VcTD) ...
... improvement across all ... survival -, ATLANTA, Dec. 9 Millennium Pharmaceuticals,Inc. ... results from the,682 patient, randomized, Phase III VISTA(1) trial. ... for stem cell,transplantation (SCT). The trial compared VELCADE, melphalan ...
Cached Medicine News:Health News:OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia 2Health News:ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference 2Health News:Novis Pharmaceuticals Hires Lisa Lopez 2Health News:Immigrant patients less likely to report family history of cancer 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 3Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 4Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 5Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 6Health News:Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy 2Health News:Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy 3Health News:Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy 4Health News:Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy 5Health News:Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy 6Health News:Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy 7
... very high frequency digital ultrasound eye arc-scanner. ... microscopic resolution images and precision measurement capabilities ... the human eye. Artemis is a very ... use, the patient leans forward placing their ...
... OTI-Scan 1000 is the most advanced ophthalmic ... system operates with a single Macintosh desktop ... with a streamlined internal probe rotator. Every ... designed. The UltraFast 12 MHz B-probe operates ...
... The AB5500 is a combination A-scan and ... capabilities. The A-scan incorporates a high frequency, ... which enables scan capture immediately upon application ... In cases where the axial length of ...
The ultimate ultrasound system for clinical ophthalmologists....
Medicine Products: